Unknown

Dataset Information

0

WMJ-8-B, a novel hydroxamate derivative, induces MDA-MB-231 breast cancer cell death via the SHP-1-STAT3-survivin cascade.


ABSTRACT: Histone deacetylase (HDAC) inhibitors have been demonstrate to have broad-spectrum anti-tumour properties and have attracted lots of attention in the field of drug discovery. However, the underlying anti-tumour mechanisms of HDAC inhibitors remain incompletely understood. In this study, we aimed to characterize the underlying mechanisms through which the novel hydroxamate-based HDAC inhibitor, WMJ-8-B, induces the death of MDA-MB-231 breast cancer cells.Effects of WMJ-8-B on cell viability, cell cycle distribution, apoptosis and signalling molecules were analysed by the MTT assay, flowcytometric analysis, immunoblotting, reporter assay, chromatin immunoprecipitation analysis and use of siRNAs. A xenograft model was used to determine anti-tumour effects of WMJ-8-B in vivo.WMJ-8-B induced survivin reduction, G2/M cell cycle arrest and apoptosis in MDA-MB-231 cells. STAT3 phosphorylation, transactivity and its binding to the survivin promoter region were reduced in WMJ-8-B-treated cells. WMJ-8-B activated the protein phosphatase SHP-1 and when SHP-1 signalling was blocked, the effects of WMJ-8-B on STAT3 phosphorylation and survivin levels were abolished. However, WMJ-8-B increased the transcription factor Sp1 binding to the p21 promoter region and enhanced p21 levels. Moreover, WMJ-8-B induced ?-tubulin acetylation and disrupted microtubule assembly. Inhibition of HDACs was shown to contribute to WMJ-8-B's actions. Furthermore, WMJ-8-B suppressed the growth of MDA-MB-231 xenografts in mammary fat pads in vivo.The SHP-1-STAT3-survivin and Sp1-p21 cascades are involved in WMJ-8-B-induced MDA-MB-231 breast cancer cell death. These results also indicate the potential of WMJ-8-B as a lead compound for treatment of breast cancer and warrant its clinical development.

SUBMITTER: Chuang YF 

PROVIDER: S-EPMC5554321 | biostudies-other | 2017 Sep

REPOSITORIES: biostudies-other

altmetric image

Publications

WMJ-8-B, a novel hydroxamate derivative, induces MDA-MB-231 breast cancer cell death via the SHP-1-STAT3-survivin cascade.

Chuang Yu-Fan YF   Huang Shiu-Wen SW   Hsu Ya-Fen YF   Yu Meng-Chieh MC   Ou George G   Huang Wei-Jan WJ   Hsu Ming-Jen MJ  

British journal of pharmacology 20170801 17


<h4>Background and purpose</h4>Histone deacetylase (HDAC) inhibitors have been demonstrate to have broad-spectrum anti-tumour properties and have attracted lots of attention in the field of drug discovery. However, the underlying anti-tumour mechanisms of HDAC inhibitors remain incompletely understood. In this study, we aimed to characterize the underlying mechanisms through which the novel hydroxamate-based HDAC inhibitor, WMJ-8-B, induces the death of MDA-MB-231 breast cancer cells.<h4>Experim  ...[more]

Similar Datasets

| S-EPMC3868635 | biostudies-literature
| S-ECPF-GEOD-20085 | biostudies-other
| S-EPMC8551752 | biostudies-literature
| S-EPMC9612085 | biostudies-literature
| S-EPMC5780039 | biostudies-literature
| S-EPMC5809808 | biostudies-literature
| S-ECPF-GEOD-64436 | biostudies-other
| S-EPMC9351117 | biostudies-literature
| S-EPMC3812178 | biostudies-literature
| S-EPMC6120250 | biostudies-literature